HCV Testing policies in the WHO European region

Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign 
C. Orkin, S. Flanagan, E. Wallis, G. Ireland, R. Dhairyawan, J. Fox, R. Nandwani, R. O'Connell, M. Lascar, J. Bulman, I. Reeves, A. Palfreeman, G. R. Foster, K. Ahmad, J. Anderson, C. Y. Tong and S. Lattimore
HIV medicine Mar 2016;17(3):222-30. doi: 10.1111/hiv.12364

Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012 
A. Mozalevskis, I. Eramova, K. Safreed-Harmon and J. V. Lazarus
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin Jun 2 2016;21(22):. doi: 10.2807/1560-7917.es.2016.21.22.30245

Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries 
P. J. Easterbrook
Journal of hepatology Oct 2016;65(1 Suppl):S46-66. doi: 10.1016/j.jhep.2016.08.002

HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions 
P. Easterbrook, C. Johnson, C. Figueroa and R. Baggaley
AIDS reviews Jan-Mar 2016;18(1):3-14. doi:

Achieving WHO recommendations for Hepatitis C Virus Elimination in Belgium 
S. Bourgeois, S. Blach, C. Blach, W. Laleman, C. Mathei, J. P. Mulkay, H. Ravazi, G. Robaeys, P. Starkel, P. Van Damme, H. Van Vlierberghe, D. Vandijck and C. Vandijck
Acta gastro-enterologica Belgica Apr-Jun 2016;79(2):222-6. doi:

2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV 
J. Bottero, C. Brouard, F. Roudot-Thoraval, S. Deuffic-Burban, P. Hofliger, A. Abergel, J. Volant, D. Dhumeaux and Y. Yazdanpanah
Liver international : official journal of the International Association for the Study of the Liver Oct 2016;36(10):1442-9. doi: 10.1111/liv.13135

WHO Guidelines Approved by the Guidelines Review Committee 

2016;():. doi:

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus 

Hepatology (Baltimore, Md.) Sep 2015;62(3):932-54. doi: 10.1002/hep.27950

Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey 
A. Bechini, A. Falla, A. Ahmad, I. Veldhuijzen, S. Boccalini, B. Porchia and M. Levi
BMC infectious diseases 2015;15():353. doi: 10.1186/s12879-015-1104-8

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage 
J. Bottero, A. Boyd, J. Gozlan, F. Carrat, J. Nau, M. D. Pauti, H. Rougier, P. M. Girard and K. Lacombe
Open forum infectious diseases Dec 2015;2(4):ofv162. doi: 10.1093/ofid/ofv162

The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014 
C. Brouard, Y. Le Strat, C. Larsen, M. Jauffret-Roustide, F. Lot and J. Pillonel
PloS one 2015;10(5):e0126920. doi: 10.1371/journal.pone.0126920

Global policy and access to new hepatitis C therapies for people who inject drugs 
J. S. Doyle, E. J. Aspinall, S. J. Hutchinson, B. Quinn, C. Gore, S. Z. Wiktor and M. E. Hellard
The International journal on drug policy Nov 2015;26(11):1064-71. doi: 10.1016/j.drugpo.2015.05.008

Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries 
N. Ford, S. Wiktor, K. Kaplan, I. Andrieux-Meyer, A. Hill, P. Radhakrishnan, P. Londeix, C. Forette, A. Momenghalibaf, A. Verster and T. Swan
The International journal on drug policy Nov 2015;26(11):1088-93. doi: 10.1016/j.drugpo.2015.05.004 Epub 2015 May 18

Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques 
C. Geue, O. Wu, Y. Xin, R. Heggie, S. Hutchinson, N. K. Martin, E. Fenwick and D. Goldberg
PloS one 2015;10(12):e0145022. doi: 10.1371/journal.pone.0145022

[Community-based screening: a motivating experience for drug users] 
L. Grammatico-Guillon, E. Arnault, S. Rollier, G. Bonnemaison, F. Dubois and E. Rusch
Sante publique (Vandoeuvre-les-Nancy, France) Sep-Oct 2015;27(5):633-9. doi:

[Chronic disease and treatment burden for patients: the example of hepatitis C] 
D. Lhuilier, F. Brugeilles and D. Rolland
Sante publique (Vandoeuvre-les-Nancy, France) Jan-Feb 2015;27(1 Suppl):S17-21. doi:

Epidemiology of hepatitis C in Croatia in the European context 
T. Vilibic-Cavlek, J. Kucinar, B. Kaic, M. Vilibic, N. Pandak, L. Barbic, V. Stevanovic and J. Vranes
World journal of gastroenterology Aug 28 2015;21(32):9476-93. doi: 10.3748/wjg.v21.i32.9476

Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey 
A. Spina, I. Eramova and J. V. Lazarus
BMC infectious diseases 2014;14 Suppl 6():S15. doi: 10.1186/1471-2334-14-s6-s15 Epub 2014 Sep 19

WHO Guidelines Approved by the Guidelines Review Committee 

2014;():. doi:

[Recent developments in serologic and molecular diagnosis of hepatitis B and C] 
M. Poljak, S. Z. Lepej and O. D. Rode
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti Oct 2013;67(4):281-90. doi:

Adherence to screening guidelines for hepatitis C among HIV-positive patients 
S. Jonckheere, A. Vincent, L. Belkhir, D. Wilmes, B. Vandercam and J. C. Yombi
AIDS patient care and STDs Jun 2013;27(6):317-9. doi: 10.1089/apc.2013.0096 Epub 2013 May 19

Predicted effects of treatment for HCV infection vary among European countries 
S. Deuffic-Burban, P. Deltenre, M. Buti, T. Stroffolini, J. Parkes, N. Muhlberger, U. Siebert, C. Moreno, A. Hatzakis, W. Rosenberg, S. Zeuzem and P. Mathurin
Gastroenterology Oct 2012;143(4):974-85.e14. doi: 10.1053/j.gastro.2012.05.054

2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines 

Liver international : official journal of the International Association for the Study of the Liver Feb 2012;32 Suppl 1():2-8. doi: 10.1111/j.1478-3231.2011.02703.x

AHRQ Comparative Effectiveness Reviews Screening for Hepatitis C Virus Infection in Adults 
M. Eisenberg Center for Clinical Decisions John and Science Communications
2007;():. doi:


Rigshospitalet, University of Copenhagen
CHIP, Department of Infectious Diseases
Section 2100, Finsencentret
Blegdamsvej 9
DK-2100 Copenhagen Ø
Tel: +45 35 45 57 57
Fax: +45 35 45 57 58
Email: hie.rigshospitalet@regionh.dk


Ann Isabelle von Lingen, Policy Officer
European AIDS Treatment Group (EATG)
Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium
Tel 32 2 626 96 41
M+32 491348317
Fax 32 2 644 33 07